No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenal Gland Neoplasms / diagnosis
-
Adrenal Gland Neoplasms / secondary
-
Adrenal Gland Neoplasms / surgery
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Brain Neoplasms / diagnostic imaging*
-
Brain Neoplasms / secondary
-
Brain Neoplasms / surgery
-
Breast Neoplasms / diagnostic imaging*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Cisplatin / therapeutic use
-
Dacarbazine / therapeutic use
-
Fatal Outcome
-
Female
-
Humans
-
Interferon-beta / therapeutic use
-
Iofetamine*
-
Liver Neoplasms / diagnostic imaging*
-
Liver Neoplasms / secondary
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / secondary
-
MART-1 Antigen / analysis
-
Mastectomy, Modified Radical
-
Melanoma / diagnostic imaging*
-
Melanoma / drug therapy
-
Melanoma / pathology
-
Middle Aged
-
Neoplasm Staging
-
Nimustine / therapeutic use
-
Nipples / diagnostic imaging*
-
Nipples / pathology
-
Radiopharmaceuticals*
-
S100 Proteins / analysis
-
Skin Neoplasms / diagnostic imaging*
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
-
Tamoxifen / therapeutic use
-
Tomography, Emission-Computed, Single-Photon
-
Vincristine / therapeutic use
Substances
-
Antineoplastic Agents
-
MART-1 Antigen
-
Radiopharmaceuticals
-
S100 Proteins
-
Tamoxifen
-
Nimustine
-
Vincristine
-
Interferon-beta
-
Dacarbazine
-
Iofetamine
-
Cisplatin